Gsa Capital Partners LLP Aim Immuno Tech Inc. Put Options Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AIM
# of Institutions
36Shares Held
8.97MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.33MShares$1.08 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$497,1760.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$174,5660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$116,0040.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il458KShares$114,4410.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $12M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...